Interleukin-6 but not soluble adhesion molecules has short-term prognostic value on mortality in patients with acute ST-segment elevation myocardial infarction

African Journal of Biotechnology

Volumn 10, Issue 8, 2011, Pages 1454-1459

  Fan, Zhen xing ^a   Hua, Qi ^a   Tan, Jing ^a   Gao, Jing ^a   Liu, Rong kun ^a   Yang, Zheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute ST segment elevation myocardial infarction; Cardiovascular mortality; Interleukin 6; Soluble intercellular adhesion molecule 1; Soluble P selectin; Soluble vascular cell adhesion molecule 1

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 79952147394     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Alpert JS, Thygesen K, Antman E, Bassand JP (2000). Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36: 959- 969.
2. Blankenberg S, Barbaux S, Tiret L (2003). Adhesion molecules and atherosclerosis. Atherosclerosis, 170: 191-203.
3. Blankenberg S, Rupprecht H, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J (2001). Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation, 104: 1336-1342.
4. Doo YC, Han SJ, Park WJ, Kim SM, Choi SH, Cho GY, Hong KS, Han KR, Lee NH, Oh DJ, Ryu KH, Rhim CY, Lee KH, Lee Y (2005). Associations between C-reactive protein and circulating cell adhesion molecules in patients with unstable angina undergoing intervention and their clinical implication. Clin. Cardiol. 28: 47-51.
5. Ferroni P, Rosa A, Di Franco M, Palmirotta R, Guadagni F, Davì G, Bertazzoni G, Basili S (2007). Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department. Clin. Chim. Acta. 381:151-156.
6. Fisman EZ, Benderly M, Esper RJ, Behar S, Boyko V, Adler Y, Tanne D, Matas Z, Tenenbaum A (2006). Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am. J. Cardiol. 98: 14-18.
7. Funayama H, Ishikawa SE, Kubo N, Yasu T, Saito M, Kawakami M (2006). Close association of regional interleukn-6 levels in the infarctrelated culprit coronary artery with restenosis in acute myocardial infarction. Circ. J. 70: 426429.
8. Hillis G, Terregino C, Taggart P, Killian A, Zhao N, Dalsey WC, Mangione A (2002). Elevated soluble P-selectin levels are associated with an increased risk of early adverse events in patients with presumed myocardial ischemia. Am. Heart J. 143: 235-241.
9. Hillis G, Terregino C, Taggart P, Killian A, Zhao N, Kaplan J, Dalsey WC, Mangione A (2001). Soluble intracellular adhesion molecule-1 as a predictor of early adverse events in patients with chest pain compatible with myocardial ischemia. Ann. Emerg. Med. 38: 223-228.
10. Koukkunen H, Penttila K, Kemppainen A, Halinen M, Penttila I, Rantanen T (2001). C-reactive protein, fibrinogen, interleukin-6 and tumor necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann. Med. 33: 37-47.
11. Libby P (2002). Inflammation in atherosclerosis. Nature, 420: 868-874.
12. Lindmark E, Diderholm E, Wallentin L, Siegbahn A (2001). Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA, 286: 2107-2113.
13. Mulvihill N, Foley J, Murphy R, Curtin R, Crean PA, Walsh M (2001). Risk stratification in unstable angina and non Q wave myocardial infarction using soluble cell adhesion molecules. Heart, 85: 623-627.
14. Nakashima Y, Raines E, Plump A, Breslow JL, Ross R (1998). Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18: 842-851.
15. Ohtsuka T, Hamada M, Inoue K, Ohshima K, Sujzuki J, Matsunaka T, Ogimoto A, Hara Y, Shigematsu Y, Higaki J (2004). Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction. Clin. Cardiol. 27: 417-420.
16. Postadzhiyan AS, Tzontcheva AV, Kehayov I, Finkov B (2008). Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clin. Biochem. 41: 126-133
17. Rallidis L, Gika H, Zolindaki M, Xydas TA, Paravolidakis KE, Velissaridou AH (2003). Usefulness of elevated levels of soluble vascular cell adhesion molecule-1 in predicting in-hospital prognosis in patients with unstable angina pectoris. Am. J. Cardiol. 92: 1195- 1197.
18. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000). Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 101: 1767- 1772.
19. Ross R (1999). Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 115-126.
20. Sukhija R, Fahdi I, Garza L, Fink L, Scott M, Aude W, Pacheco R, Bursac Z, Grant A, Mehta JL (2007). Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am. J. Cardiol. 99: 879-884.
21. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000). Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis, 148: 209-214.